Indications and Purposes
| 1 Indications And Usage Arimidex Is An Aromatase Inhibitor Indicated For: • Adjuvant Treatment Of Postmenopausal Women With Hormone Receptor-Positive Early Breast Cancer ( 1.1 ) • First-Line Treatment Of Postmenopausal Women With Hormone Receptor-Positive Or Hormone Receptor-Unknown Locally Advanced Or Metastatic Breast Cancer ( 1.2 ) • Treatment Of Advanced Breast Cancer In Postmenopausal Women With Disease Progression Following Tamoxifen Therapy. Patients With Er-Negative Disease And Patients Who Did Not Respond To Previous Tamoxifen Therapy Rarely Responded To Arimidex ( 1.3 ) 1.1 Adjuvant Treatment Arimidex Is Indicated For Adjuvant Treatment Of Postmenopausal Women With Hormone Receptor-Positive Early Breast Cancer. 1.2 First-Line Treatment Arimidex Is Indicated For The First-Line Treatment Of Postmenopausal Women With Hormone Receptor-Positive Or Hormone Receptor-Unknown Locally Advanced Or Metastatic Breast Cancer. 1.3 Second-Line Treatment Arimidex Is Indicated For The Treatment Of Advanced Breast Cancer In Postmenopausal Women With Disease Progression Following Tamoxifen Therapy. Patients With Er-Negative Disease And Patients Who Did Not Respond To Previous Tamoxifen Therapy Rarely Responded To Arimidex. |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Anastrozole |
|
ZINC941 |